MicroRNA-mediated control of prostate cancer metastasis

Implications for the identification of novel biomarkers and therapeutic targets

Nicola Fenderico, Anna Casamichele, Valentina Profumo, Nadia Zaffaroni, Paolo Gandellini

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Prostate cancer is the most prevalent tumor in the male population and the second leading cause of cancerrelated death in men in Western countries. Besides genetic and epigenetic aberrations in protein coding genes, alterations in microRNAs equally contribute to prostate cancer initiation and progression. In this context, a plethora of overwhelming evidence establishes the involvement of microRNAs as essential actors in the multi-step cascade fostering a prostate cancer cell to leave the primary tumor and form secondary tumors at distant sites. Herein, we describe how specific microRNAs may impinge on the different stages of prostate cancer metastasis and review published profiling studies in which microRNA expression data have been analyzed in relation to clinical parameters of progression for the identification of novel biomarkers. We also provide evidence concerning the possibility to manipulate metastasis-related microRNA functions, either by mimicking or inhibiting them, as a highly promising strategy for the development of innovative therapeutic approaches for the advanced disease.

Original languageEnglish
Pages (from-to)1566-1584
Number of pages19
JournalCurrent Medicinal Chemistry
Volume20
Issue number12
DOIs
Publication statusPublished - Apr 2013

Fingerprint

Biomarkers
MicroRNAs
Prostatic Neoplasms
Neoplasm Metastasis
Tumors
Therapeutics
Neoplasms
Foster Home Care
Aberrations
Epigenomics
Cause of Death
Genes
Cells
Population
Proteins

Keywords

  • Antagomir
  • Circulating miRNA
  • LNA
  • Metastasis
  • MicroRNA
  • Prognosis
  • Prostate cancer
  • Therapy

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

MicroRNA-mediated control of prostate cancer metastasis : Implications for the identification of novel biomarkers and therapeutic targets. / Fenderico, Nicola; Casamichele, Anna; Profumo, Valentina; Zaffaroni, Nadia; Gandellini, Paolo.

In: Current Medicinal Chemistry, Vol. 20, No. 12, 04.2013, p. 1566-1584.

Research output: Contribution to journalArticle

Fenderico, Nicola ; Casamichele, Anna ; Profumo, Valentina ; Zaffaroni, Nadia ; Gandellini, Paolo. / MicroRNA-mediated control of prostate cancer metastasis : Implications for the identification of novel biomarkers and therapeutic targets. In: Current Medicinal Chemistry. 2013 ; Vol. 20, No. 12. pp. 1566-1584.
@article{32c8e759f86f4d839c74f63ee1ce89db,
title = "MicroRNA-mediated control of prostate cancer metastasis: Implications for the identification of novel biomarkers and therapeutic targets",
abstract = "Prostate cancer is the most prevalent tumor in the male population and the second leading cause of cancerrelated death in men in Western countries. Besides genetic and epigenetic aberrations in protein coding genes, alterations in microRNAs equally contribute to prostate cancer initiation and progression. In this context, a plethora of overwhelming evidence establishes the involvement of microRNAs as essential actors in the multi-step cascade fostering a prostate cancer cell to leave the primary tumor and form secondary tumors at distant sites. Herein, we describe how specific microRNAs may impinge on the different stages of prostate cancer metastasis and review published profiling studies in which microRNA expression data have been analyzed in relation to clinical parameters of progression for the identification of novel biomarkers. We also provide evidence concerning the possibility to manipulate metastasis-related microRNA functions, either by mimicking or inhibiting them, as a highly promising strategy for the development of innovative therapeutic approaches for the advanced disease.",
keywords = "Antagomir, Circulating miRNA, LNA, Metastasis, MicroRNA, Prognosis, Prostate cancer, Therapy",
author = "Nicola Fenderico and Anna Casamichele and Valentina Profumo and Nadia Zaffaroni and Paolo Gandellini",
year = "2013",
month = "4",
doi = "10.2174/0929867311320120007",
language = "English",
volume = "20",
pages = "1566--1584",
journal = "Current Medicinal Chemistry",
issn = "0929-8673",
publisher = "Bentham Science Publishers B.V.",
number = "12",

}

TY - JOUR

T1 - MicroRNA-mediated control of prostate cancer metastasis

T2 - Implications for the identification of novel biomarkers and therapeutic targets

AU - Fenderico, Nicola

AU - Casamichele, Anna

AU - Profumo, Valentina

AU - Zaffaroni, Nadia

AU - Gandellini, Paolo

PY - 2013/4

Y1 - 2013/4

N2 - Prostate cancer is the most prevalent tumor in the male population and the second leading cause of cancerrelated death in men in Western countries. Besides genetic and epigenetic aberrations in protein coding genes, alterations in microRNAs equally contribute to prostate cancer initiation and progression. In this context, a plethora of overwhelming evidence establishes the involvement of microRNAs as essential actors in the multi-step cascade fostering a prostate cancer cell to leave the primary tumor and form secondary tumors at distant sites. Herein, we describe how specific microRNAs may impinge on the different stages of prostate cancer metastasis and review published profiling studies in which microRNA expression data have been analyzed in relation to clinical parameters of progression for the identification of novel biomarkers. We also provide evidence concerning the possibility to manipulate metastasis-related microRNA functions, either by mimicking or inhibiting them, as a highly promising strategy for the development of innovative therapeutic approaches for the advanced disease.

AB - Prostate cancer is the most prevalent tumor in the male population and the second leading cause of cancerrelated death in men in Western countries. Besides genetic and epigenetic aberrations in protein coding genes, alterations in microRNAs equally contribute to prostate cancer initiation and progression. In this context, a plethora of overwhelming evidence establishes the involvement of microRNAs as essential actors in the multi-step cascade fostering a prostate cancer cell to leave the primary tumor and form secondary tumors at distant sites. Herein, we describe how specific microRNAs may impinge on the different stages of prostate cancer metastasis and review published profiling studies in which microRNA expression data have been analyzed in relation to clinical parameters of progression for the identification of novel biomarkers. We also provide evidence concerning the possibility to manipulate metastasis-related microRNA functions, either by mimicking or inhibiting them, as a highly promising strategy for the development of innovative therapeutic approaches for the advanced disease.

KW - Antagomir

KW - Circulating miRNA

KW - LNA

KW - Metastasis

KW - MicroRNA

KW - Prognosis

KW - Prostate cancer

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=84877997207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877997207&partnerID=8YFLogxK

U2 - 10.2174/0929867311320120007

DO - 10.2174/0929867311320120007

M3 - Article

VL - 20

SP - 1566

EP - 1584

JO - Current Medicinal Chemistry

JF - Current Medicinal Chemistry

SN - 0929-8673

IS - 12

ER -